
Thomson Medical Group warns of FY2025 loss
The decline is attributable to higher interest expenses.
Thomson Medical Group Limited (TMG) is expected to post a loss after tax for the six months ended 30 June 2025 and the full financial year, following a preliminary review of its unaudited results.
The loss is attributable to higher interest expenses from the FEMVN acquisition, cessation of projects in Singapore, and weaker performance in Malaysia, according to TMG.
The company is finalising its unaudited financial results for the period.
Meanwhile, the board has advised shareholders and investors to exercise caution when trading its securities.